改良活传染性法氏囊病病毒疫苗较火鸡疱疹病毒载体IBDV疫苗延迟新生肉鸡变异IBDV感染
在IBDV母源抗体阳性雏鸡(n=330,6组,每组50–60只)中比较改良活(MdLV)IBDV疫苗与火鸡疱疹病毒(HVT)-IBDV载体疫苗对早期变异IBDV(varIBDV)感染的保护效果。HVT-IBDV经卵内接种18日龄鸡胚,MdLV于1日龄肉鸡皮下接种,部分组于孵化后第6天口服varIBDV(SK-09,3×10^3 EID50)攻毒。结果显示MdLV延迟varIBDV致病,而HVT-IBDV疫苗可能具有免疫抑制作用。
要点
- 19日龄时varIBDV-SK09攻毒引起HVT-IBDV接种鸡严重法氏囊萎缩和较低法氏囊/体重比,MdLV接种鸡未见此变化。
- 35日龄时所有攻毒组均出现法氏囊萎缩和血清转阳;RT-qPCR显示9日龄时HVT-IBDV接种组病毒载量约5744倍,未接种攻毒组约2.25倍。
- 流式细胞术显示HVT-IBDV接种后细胞毒性CD8+ T细胞反应受抑制(CD44下调)且脾淋巴细胞计数降低。
核心结论
- 数据提示MdLV延迟varIBDV致病,而HVT-IBDV疫苗可能具有免疫抑制作用,可能增加肉鸡早期varIBDV感染风险。
研究设计与样本
- 在IBDV母源抗体阳性雏鸡(n=330)中开展实验,分为6组(每组50–60只):组1(生理盐水)、组2(生理盐水+varIBDV)、组3(HVT-IBDV)、组4(HVT-IBDV+varIBDV)、组5(MdLV)、组6(MdLV+varIBDV)。
- HVT-IBDV经卵内途径接种18日龄鸡胚,MdLV于1日龄肉鸡皮下接种;组2、组4、组6于孵化后第6天口服varIBDV(SK-09,3×10^3 EID50)攻毒。
- 于19日龄和35日龄评估IBDV血清转阳、法氏囊/体重比(BBW)和法氏囊组织病理学。
主要发现
- 19日龄组织病理学检查显示,varIBDV-SK09攻毒在HVT-IBDV接种鸡中引起严重法氏囊萎缩和较低BBW,但在MdLV接种鸡中未见。
- 35日龄时所有攻毒组均出现法氏囊萎缩和血清转阳。
- RT-qPCR分析显示攻毒后9日龄时HVT-IBDV接种组病毒载量约5744倍,未接种攻毒组约2.25倍。
- 流式细胞术显示HVT-IBDV接种后雏鸡细胞毒性CD8+ T细胞反应受抑制(CD44下调)且脾淋巴细胞计数降低。
关键数值与推荐
- varIBDV攻毒剂量为SK-09株3×10^3 EID50,经口途径于孵化后第6天给予。
- HVT-IBDV于18日龄鸡胚经卵内接种,MdLV于1日龄肉鸡皮下接种。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Chickens are commonly processed around 35-45days of age in broiler chicken industry hence; diseases that occur at a young age are of paramount economic importance. Early age infection with infectious bursal disease virus (IBDV) results in long-lasting immunosuppression and profound economic losses. To our knowledge, this is the first study comparing the protection efficacy of modified live (MdLV) IBDV and herpesvirus turkey (HVT)-IBDV vaccines against early age variant IBDV (varIBDV) infection in chicks. Experiments were carried out in IBDV maternal antibody (MtAb) positive chicks (n=330), divided into 6 groups (n=50-60/group), namely Group 1 (saline), Group 2 (saline+varIBDV), Group 3 (HVT-IBDV), Group 4 (HVT-IBDV+varIBDV), Group 5 (MdLV) and Group 6 (MdLV+varIBDV). HVT-IBDV vaccination was given via the in ovo route to 18-day-old embryonated eggs. MdLV was administered via the subcutaneous route in day-old broilers. Group 2, Group 4 and Group 6 were orally challenged with varIBDV (SK-09, 3×103 EID50) at day 6 post-hatch. IBDV seroconversion, bursal weight to body weight ratio (BBW) and bursal histopathology were assessed at 19 and 35days of age. Histopathological examination at day 19 revealed that varIBDV-SK09 challenge caused severe bursal atrophy and lower BBW in HVT-IBDV but not in MdLV vaccinated chicks. However by day 35, all challenged groups showed bursal atrophy and seroconversion. Interestingly, RT-qPCR analysis after varIBDV-SK09 challenge demonstrated an early (9days of age) and significantly high viral load (∼5744 folds) in HVT-IBDV vaccinated group vs unvaccinated challenged group (∼2.25 folds). Furthermore, flow cytometry analysis revealed inhibition of cytotoxic CD8+ T-cell response (CD44-downregulation) and decreased splenic lymphocytes counts in chicks after HVT-IBDV vaccination. Overall, our data suggest that MdLV delays varIBDV pathogenesis, whereas, HVT-IBDV vaccine is potentially immunosuppressive, which may increase the risk of early age varIBDV infection in broilers.
引用
- Kurukulasuriya S, Ahmed KA, Ojkic D, et al. Modified live infectious bursal disease virus (IBDV) vaccine delays infection of neonatal broiler chickens with variant IBDV compared to turkey herpesvirus (HVT)-IBDV vectored vaccine. Vaccine. 2017. PMID: 28089549. doi:10.1016/j.vaccine.2017.01.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。